KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adaptive Biotechnologies (ADPT) Total Debt: 2022-2024

Historic Total Debt for Adaptive Biotechnologies (ADPT) over the last 3 years, with Dec 2024 value amounting to $133.3 million.

  • Adaptive Biotechnologies' Total Debt fell 0.65% to $131.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $131.8 million, marking a year-over-year decrease of 0.65%. This contributed to the annual value of $133.3 million for FY2024, which is 2.00% up from last year.
  • Adaptive Biotechnologies' Total Debt amounted to $133.3 million in FY2024, which was up 2.00% from $130.7 million recorded in FY2023.
  • In the past 5 years, Adaptive Biotechnologies' Total Debt registered a high of $133.3 million during FY2024, and its lowest value of $125.4 million during FY2022.
  • Over the past 3 years, Adaptive Biotechnologies' median Total Debt value was $130.7 million (recorded in 2023), while the average stood at $129.8 million.
  • Data for Adaptive Biotechnologies' Total Debt shows a peak YoY rose of 4.23% (in 2023) over the last 5 years.
  • Over the past 3 years, Adaptive Biotechnologies' Total Debt (Yearly) stood at $125.4 million in 2022, then increased by 4.23% to $130.7 million in 2023, then climbed by 2.00% to $133.3 million in 2024.